Prediabetes: Definition and Clinical Significance
Prediabetes is a metabolic condition characterized by blood glucose levels that are higher than normal but not yet high enough to be diagnosed as diabetes, indicating increased risk for developing type 2 diabetes and cardiovascular disease. 1
Definition and Diagnostic Criteria
Prediabetes is diagnosed when one or more of the following criteria are met:
- Impaired Fasting Glucose (IFG): Fasting plasma glucose levels of 100-125 mg/dL (5.6-6.9 mmol/L)
- Impaired Glucose Tolerance (IGT): 2-hour plasma glucose levels during 75-g oral glucose tolerance test of 140-199 mg/dL (7.8-11.0 mmol/L)
- Hemoglobin A1C (HbA1C): 5.7-6.4% (39-47 mmol/mol) 1
It's important to note that the World Health Organization (WHO) defines the IFG cutoff at 110 mg/dL (6.1 mmol/L), which differs from the American Diabetes Association criteria. 1
Epidemiology and Risk
Prediabetes affects approximately:
- 1 in 3 adults in the US
- 720 million individuals worldwide 2
The progression rate from prediabetes to diabetes is significant:
- Approximately 10% of people with prediabetes progress to diabetes each year in the US 2
- The risk increases disproportionately as A1C rises 1
Risk Factors for Prediabetes
Individuals at higher risk for prediabetes include those who are:
- Overweight or obese (BMI ≥25 kg/m² or ≥23 kg/m² in Asian Americans)
- Physically inactive
- Have a first-degree relative with diabetes
- Belong to high-risk racial/ethnic groups (e.g., African American, Latino, Native American, Asian American, Pacific Islander)
- Have history of cardiovascular disease
- Have hypertension (≥130/80 mmHg or on therapy)
- Have HDL cholesterol <35 mg/dL and/or triglycerides >250 mg/dL
- Women with polycystic ovary syndrome
- Individuals with conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans) 1
Health Implications
Prediabetes is not merely a risk factor for diabetes but carries its own health risks:
- Increased mortality (excess absolute risk of 7.36 per 10,000 person-years)
- Increased cardiovascular events (excess absolute risk of 8.75 per 10,000 person-years) 2
- Associated with microvascular and macrovascular disease 3
Screening Recommendations
The American Diabetes Association recommends:
- Testing should begin at age 35 years for all individuals
- Earlier testing for those who are overweight/obese with additional risk factors
- Testing every 3 years if results are normal
- Annual testing for those with prediabetes
- Testing every 3 years (minimum) for women with history of gestational diabetes 1
Pathophysiology
Prediabetes involves:
- Insulin resistance
- Insulin secretory dysfunction
- Both abnormalities are present before diabetes develops 4
Clinical Significance
Understanding prediabetes is crucial because:
- It identifies individuals at high risk for developing diabetes
- It presents an opportunity for intervention before diabetes develops
- It signals increased cardiovascular and mortality risk independent of progression to diabetes
- Interventions at this stage can be highly effective in preventing or delaying diabetes 2, 5
Common Pitfalls in Prediabetes Management
- Failing to recognize prediabetes as a serious health condition rather than just a risk factor
- Using inconsistent diagnostic criteria (multiple definitions exist)
- Not screening high-risk individuals according to guidelines
- Missing opportunities for intervention in this critical window
- Overlooking the cardiovascular and mortality risks associated with prediabetes itself
Prediabetes should be viewed as an opportunity for intervention rather than simply a "pre-disease" state, as effective treatments exist that can significantly reduce progression to diabetes and improve cardiovascular outcomes.